Search

Andrew Stephen Felts

from Murfreesboro, TN
Age ~48
Get Report
Also known as:
Andrew S Felts
Related to:
Mary Jo Christian, 77Nicholas Marinelli, 77Carrie Braun, 55Jessica ChristianAmy L Koch, 57Janie Christian
Connected to:
Adriana R Felts, 56Britney N Felts, 35Elena M Felts, 34Evan Felts, 70Jasmine Felts, 34Jeffery S Felts, 58Kaitlyn E Felts, 28Katrina L Felts, 70Marty Felts, 64Melissa D Felts, 53

Andrew Felts Phones & Addresses

  • Murfreesboro, TN
  • Brentwood, TN
  • Nashville, TN
  • 6317 New Hope Rd, Hermitage, TN 37076 (615) 889-0073 (615) 889-8718
  • 212 17Th St SW, Knoxville, TN 37916
  • Tallahassee, FL

Work

Company: Akerman LLP Address:

Specialities

Real Estate Acquisitions • Commercial Real Estate Acquisitions • Commercial Leasing • Foreclosures • Health Care • Litigation • Tax

Professional Records

Lawyers & Attorneys

Andrew Felts Photo 1

Andrew Felts - Lawyer

View page
Office:
Akerman LLP
Specialties:
Real Estate Acquisitions
Commercial Real Estate Acquisitions
Commercial Leasing
Foreclosures
Health Care
Litigation
Tax
ISLN:
922460181
Admitted:
2012
University:
University of North Carolina at Chapel Hill, B.A., 2009
Law School:
West Virginia University College of Law, J.D., 2012

Resumes

Resumes

Andrew Felts Photo 2

Andrew Felts

View page
Location:
United States
Andrew Felts Photo 3

Andrew Felts

View page
Location:
United States

Publications

Us Patents

Indoleacetic Acid And Indenacetic Acid Derivatives As Therapeutic Agents With Reduced Gastrointestinal Toxicity

View page
US Patent:
8168656, May 1, 2012
Filed:
Jan 5, 2009
Appl. No.:
12/319262
Inventors:
Lawrence J. Marnett - Nashville TN, US
Jeffery J. Prusakiewicz - Nashville TN, US
Andrew S. Felts - Nashville TN, US
Chuan Ji - Nashville TN, US
Assignee:
Vanderbilt University - Nashville TN
International Classification:
A61K 31/47
C07D 453/02
US Classification:
514311, 546134
Abstract:
The presently disclosed subject matter provides derivatives of non-steroidal anti-inflammatory drugs (NSAIDs) that are characterized by substantially reduced cyclooxygenase inhibiting activity, yet retain the ability to interact with and modulate the activities of other polypeptides such as the class of peroxisome proliferators-activated receptors (PPARs) and γ-secretase. Also provided are methods of using the derivatives to treat pathological disorders.

Substituted Phenylamine Carboxamide Analogs As Mglur5 Negative Allosteric Modulators And Methods Of Making And Using The Same

View page
US Patent:
8501757, Aug 6, 2013
Filed:
Sep 17, 2010
Appl. No.:
12/885420
Inventors:
P. Jeffrey Conn - Brentwood TN, US
Craig W. Lindsley - Brentwood TN, US
Kyle A. Emmitte - Spring Hill TN, US
Charles David Weaver - Franklin TN, US
Alice L. Rodriguez - Nashville TN, US
Andrew S. Felts - Nashville TN, US
Carrie K. Jones - Nashville TN, US
Brittney S. Bates - Nashville TN, US
Brian A. Chauder - Smyrna TN, US
Assignee:
Vanderbilt University - Nashville TN
International Classification:
A61K 31/505
A61K 31/44
C07D 239/02
C07D 403/12
C07D 401/12
C07D 213/62
A61K 31/4965
US Classification:
514272, 51425505, 514333, 514335
Abstract:
Disclosed are negative allosteric modulators of the metabotropic glutamate receptor subtype 5 (mGluR5); synthetic methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of treating neurological and psychiatric disorders associated with glutamate dysfunction using the compounds and compositions. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

Substituted Heteroarylamine Carboxamide Analogs As Mglur5 Negative Allosteric Modulators And Methods Of Making And Using The Same

View page
US Patent:
8569308, Oct 29, 2013
Filed:
Sep 17, 2010
Appl. No.:
12/885245
Inventors:
P. Jeffrey Conn - Brentwood TN, US
Craig W. Lindsley - Brentwood TN, US
Kyle A. Emmitte - Spring Hill TN, US
Charles David Weaver - Franklin TN, US
Alice L. Rodriguez - Nashville TN, US
Andrew S. Felts - Nashville TN, US
Carrie K. Jones - Nashville TN, US
Brittney S. Bates - Nashville TN, US
Assignee:
Vanderbilt University - Nashville TN
International Classification:
A01N 37/30
A61K 31/205
US Classification:
51425505, 544295
Abstract:
Disclosed are negative allosteric modulators of the metabotropic glutamate receptor subtype 5 (mGluR5); synthetic methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of treating neurological and psychiatric disorders associated with glutamate dysfunction using the compounds and compositions. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

Substituted Heteroarylamide Analogs As Mglur5 Negative Allosteric Modulators And Methods Of Making And Using The Same

View page
US Patent:
8598345, Dec 3, 2013
Filed:
Sep 17, 2010
Appl. No.:
12/885289
Inventors:
P. Jeffrey Conn - Brentwood TN, US
Craig W. Lindsley - Brentwood TN, US
Kyle A. Emmitte - Spring Hill TN, US
Charles David Weaver - Franklin TN, US
Alice L. Rodriguez - Nashville TN, US
Andrew S. Felts - Nashville TN, US
Carrie K. Jones - Nashville TN, US
Brittney S. Bates - Nashville TN, US
Assignee:
Vanderbilt University - Nashville TN
International Classification:
C07D 401/12
C07D 213/65
A61P 29/00
A61P 25/22
US Classification:
544333, 546261
Abstract:
Disclosed are negative allosteric modulators of the metabotropic glutamate receptor subtype 5 (mGluR5); synthetic methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of treating neurological and psychiatric disorders associated with glutamate dysfunction using the compounds and compositions. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

Indoleacetic Acid And Indenacetic Acid Derivatives As Therapeutic Agents With Reduced Gastrointestinal Toxicity

View page
US Patent:
20050250839, Nov 10, 2005
Filed:
Apr 26, 2005
Appl. No.:
11/114921
Inventors:
Lawrence Marnett - Nashville TN, US
Jeffery Prusakiewicz - Nashville TN, US
Andrew Felts - Nashville TN, US
Chuan Ji - Nashville TN, US
International Classification:
A61K031/405
US Classification:
514420000
Abstract:
The presently disclosed subject matter provides derivatives of non-steroidal anti-inflammatory drugs (NSAIDs) that are characterized by substantially reduced cyclooxygenase inhibiting activity, yet retain the ability to interact with and modulate the activities of other polypeptides such as the class of peroxisome proliferators-activated receptors (PPARs) and γ-secretase. Also provided are methods of using the derivatives to treat pathological disorders.

Substituted Benzamide Analogs As Mglur5 Negative Allosteric Modulators And Methods Of Making And Using The Same

View page
US Patent:
20110152299, Jun 23, 2011
Filed:
Sep 17, 2010
Appl. No.:
12/885378
Inventors:
P. Jeffrey Conn - Brentwood TN, US
Craig W. Lindsley - Brentwood TN, US
Kyle A. Emmitte - Spring Hill TN, US
Charles David Weaver - Franklin TN, US
Alice L. Rodriguez - Nashville TN, US
Andrew S. Felts - Nashville TN, US
Carrie K. Jones - Nashville TN, US
International Classification:
A61K 31/506
C07D 401/12
A61K 31/4439
C07D 403/12
A61P 25/22
A61P 25/16
A61P 29/00
A61P 1/04
US Classification:
514269, 5462707, 514342, 544298
Abstract:
Disclosed are negative allosteric modulators of the metabotropic glutamate receptor subtype 5 (mGluR5); synthetic methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of treating neurological and psychiatric disorders associated with glutamate dysfunction using the compounds and compositions. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention

Indazole Compounds As Mglur4 Allosteric Potentiators, Compositions, And Methods Of Treating Neurological Dysfunction

View page
US Patent:
20220259190, Aug 18, 2022
Filed:
Apr 26, 2022
Appl. No.:
17/730112
Inventors:
- Nashville TN, US
Craig W. Lindsley - Nashville TN, US
Andrew S. Felts - Nashville TN, US
Colleen M. Niswender - Nashville TN, US
Rory A. Capstick - Nashville TN, US
Paul K. Spearing - Nashville TN, US
Sean R. Bollinger - Nashville TN, US
International Classification:
C07D 405/14
C07D 407/14
A61P 25/00
C07D 409/14
C07D 519/00
C07D 401/12
C07D 471/04
Abstract:
Indazole compounds which are useful as allosteric potentiators/positive allosteric modulators of the metabotropic glutamate receptor subtype 4 (mGluR4); synthetic methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of using the compounds, for example, in treating neurological and psychiatric disorders or other disease states associated with glutamate dysfunction.

Indazole Compounds As Mglur4 Allosteric Potentiators, Compositions, And Methods Of Treating Neurological Dysfunction

View page
US Patent:
20200291019, Sep 17, 2020
Filed:
Aug 16, 2018
Appl. No.:
16/639539
Inventors:
- Nashville TN, US
Craig W. Lindsley - Brentwood TN, US
Andrew S. Felts - Brentwood TN, US
Colleen M. Niswender - Brentwood TN, US
Rory A. Capstick - Nashville TN, US
Paul K. Spearing - Chapel Hill TN, US
Sean R. Bollinger - Murfreesboro TN, US
International Classification:
C07D 471/04
C07D 519/00
C07D 409/14
C07D 405/14
Abstract:
Indazole compounds which are useful as allosteric potentiators/positive allosteric modulators of the metabotropic glutamate receptor subtype 4 (mGluR4); synthetic methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of using the compounds, for example, in treating neurological and psychiatric disorders or other disease states associated with glutamate dysfunction.
Control profile
Andrew Stephen Felts from Murfreesboro, TN, age ~48 Get Report